Macalinggit, Kent Brylle .

HRN: 26-83-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
CEFUROXIME 750MG (VIAL)
04/17/2026
04/24/2026
IV
500mg
Q8
PCAP C; UTI
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractPneumoniaProphylaxis    Compliance to guidelines: